Venker Eric
President & Immunovant CEO
- Shares
- 14,144
- Price
- $35.42
- Value
- $500,980
ROIV
4 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$59,859,518
0 buyers · 4 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$878,527,379
12 distinct insiders
Highlighted alerts
73
27 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
ROIV overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date. Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.
Voluntary purchases and sales; administrative noise stays hidden.
Venker Eric
President & Immunovant CEO
Venker Eric
President & Immunovant CEO
Epperly Melissa B,
Director
Epperly Melissa B,
Director
Venker Eric
President & Immunovant CEO
Epperly Melissa B,
Director
Epperly Melissa B,
Director
Fitzgerald Meghan
Director
Fitzgerald Meghan
Director
Fitzgerald Meghan
Director
Venker Eric
President & Immunovant CEO
Venker Eric
President & Immunovant CEO
Sukhatme Mayukh
President & CIO
Sukhatme Mayukh
President & CIO
Sukhatme Mayukh
President & CIO
Sukhatme Mayukh
President & CIO
Sukhatme Mayukh
President & CIO
Sukhatme Mayukh
President & CIO
Sukhatme Mayukh
President & CIO
Venker Eric
President & Immunovant CEO
Fitzgerald Meghan
Director
MANCHESTER KEITH S
Director
MANCHESTER KEITH S
Director
Gold Daniel Allen
Director
QVT Financial LP
Director by Deputization
Epperly Melissa B,
Director
Epperly Melissa B,
Director
MANCHESTER KEITH S
Director
MANCHESTER KEITH S
Director
Gold Daniel Allen
Director
Gold Daniel Allen
Director
QVT Financial LP
Director by Deputization
QVT Financial LP
Director by Deputization
Sukhatme Mayukh
President & CIO
MANCHESTER KEITH S
Director
MANCHESTER KEITH S
Director
Gold Daniel Allen
Director
Gold Daniel Allen
Director
QVT Financial LP
Director by Deputization
QVT Financial LP
Director by Deputization
Sukhatme Mayukh
President & CIO
Venker Eric
President & Immunovant CEO
Venker Eric
President & Immunovant CEO
Venker Eric
President & Immunovant CEO
Venker Eric
President & Immunovant CEO
Gline Matthew
CEO
Humes Jennifer
Chief Accounting Officer
Fitzgerald Meghan
Director
Venker Eric
President & Immunovant CEO
Epperly Melissa B,
Director
Torti Frank
President and Vant Chair
Torti Frank
President and Vant Chair
Torti Frank
President and Vant Chair
Venker Eric
President & Immunovant CEO
MANCHESTER KEITH S
Director
MANCHESTER KEITH S
Director
Gold Daniel Allen
Director
Gold Daniel Allen
Director
QVT Financial LP
Director by Deputization
QVT Financial LP
Director by Deputization
MANCHESTER KEITH S
Director
MANCHESTER KEITH S
Director
Gold Daniel Allen
Director
Gold Daniel Allen
Director
QVT Financial LP
Director by Deputization
QVT Financial LP
Director by Deputization
MANCHESTER KEITH S
Director
Gold Daniel Allen
Director
QVT Financial LP
Director by Deputization
Sukhatme Mayukh
President & CIO
Venker Eric
President & Immunovant CEO
Sukhatme Mayukh
President & CIO
Sukhatme Mayukh
President & CIO
Pulik Richard
CFO
Pulik Richard
CFO
Gold Daniel Allen
Director
Gold Daniel Allen
Director
Gold Daniel Allen
Director
MANCHESTER KEITH S
Director
MANCHESTER KEITH S
Director
MANCHESTER KEITH S
Director
QVT Financial LP
Director by Deputization
QVT Financial LP
Director by Deputization
QVT Financial LP
Director by Deputization
Sukhatme Mayukh
President & CIO
Gold Daniel Allen
Director
Gold Daniel Allen
Director
MANCHESTER KEITH S
Director
MANCHESTER KEITH S
Director
QVT Financial LP
Director by Deputization
QVT Financial LP
Director by Deputization
Ramaswamy Vivek
10% owner
Gline Matthew
CEO
Gline Matthew
CEO
Gline Matthew
CEO
Ramaswamy Vivek
10% owner
Ramaswamy Vivek
10% owner
Venker Eric
President & Immunovant CEO
MANCHESTER KEITH S
Director
MANCHESTER KEITH S
Director
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | Venker Eric President & Immunovant CEO | Sale | 14,144 | $35.42 | $500,980 | |
| Oct 20, 2026 | Venker Eric President & Immunovant CEO | Sale | 185,856 | $35.09 | $6,521,687 | |
| Oct 01, 2026 | Epperly Melissa B, Director | Sale | 900 | $36.57 | $32,913 | |
| Oct 01, 2026 | Epperly Melissa B, Director | Sale | 16,850 | $36.08 | $607,948 | |
| Sep 30, 2026 | Venker Eric President & Immunovant CEO | Sale | 200,000 | $36.62 | $7,324,000 | |
| Sep 15, 2026 | Epperly Melissa B, Director | Sale | 600 | $40.38 | $24,228 | |
| Sep 15, 2026 | Epperly Melissa B, Director | Sale | 4,338 | $39.65 | $172,002 | |
| Sep 15, 2026 | Fitzgerald Meghan Director | Sale | 400 | $40.45 | $16,180 | |
| Sep 15, 2026 | Fitzgerald Meghan Director | Sale | 4,712 | $39.68 | $186,972 | |
| Sep 08, 2026 | Fitzgerald Meghan Director | Sale | 20,000 | $39.90 | $798,000 | |
| Aug 28, 2026 | Venker Eric President & Immunovant CEO | Sale | 33,818 | $36.44 | $1,232,328 | |
| Aug 28, 2026 | Venker Eric President & Immunovant CEO | Sale | 166,182 | $35.63 | $5,921,065 | |
| Aug 21, 2026 | Sukhatme Mayukh President & CIO | Sale | 144,756 | $36.48 | $5,280,699 | |
| Aug 20, 2026 | Sukhatme Mayukh President & CIO | Sale | 17,519 | $37.30 | $653,459 | |
| Aug 19, 2026 | Sukhatme Mayukh President & CIO | Sale | 172,899 | $37.17 | $6,426,656 | |
| Aug 18, 2026 | Sukhatme Mayukh President & CIO | Sale | 31,801 | $37.18 | $1,182,361 | |
| Aug 18, 2026 | Sukhatme Mayukh President & CIO | Sale | 105,141 | $36.59 | $3,847,109 | |
| Aug 17, 2026 | Sukhatme Mayukh President & CIO | Sale | 284,707 | $36.25 | $10,320,629 | |
| Aug 14, 2026 | Sukhatme Mayukh President & CIO | Sale | 243,177 | $36.23 | $8,810,303 | |
| Jul 27, 2026 | Venker Eric President & Immunovant CEO | Sale | 200,000 | $34.95 | $6,990,000 | |
| Jun 30, 2026 | Fitzgerald Meghan Director | Sale | 10,000 | $34.90 | $349,000 | |
| Jun 30, 2026 | MANCHESTER KEITH S Director | Sale | 200,000 | $35.45 | $7,090,000 | |
| Jun 30, 2026 | MANCHESTER KEITH S Director | Sale | 12,380 | $35.28 | $436,766 | |
| Jun 30, 2026 | Gold Daniel Allen Director | Sale | 12,380 | $35.28 | $436,766 | |
| Jun 30, 2026 | QVT Financial LP Director by Deputization | Sale | 12,380 | $35.28 | $436,766 | |
| Jun 29, 2026 | Epperly Melissa B, Director | Sale | 2,748 | $34.71 | $95,383 | |
| Jun 29, 2026 | Epperly Melissa B, Director | Sale | 15,002 | $34.32 | $514,869 | |
| Jun 29, 2026 | MANCHESTER KEITH S Director | Sale | 600,000 | $34.59 | $20,754,000 | |
| Jun 29, 2026 | MANCHESTER KEITH S Director | Sale | 200,000 | $34.44 | $6,888,000 | |
| Jun 29, 2026 | Gold Daniel Allen Director | Sale | 600,000 | $34.59 | $20,754,000 | |
| Jun 29, 2026 | Gold Daniel Allen Director | Sale | 200,000 | $34.44 | $6,888,000 | |
| Jun 29, 2026 | QVT Financial LP Director by Deputization | Sale | 600,000 | $34.59 | $20,754,000 | |
| Jun 29, 2026 | QVT Financial LP Director by Deputization | Sale | 200,000 | $34.44 | $6,888,000 | |
| Jun 26, 2026 | Sukhatme Mayukh President & CIO | Sale | 500,000 | $34.08 | $17,040,000 | |
| Jun 26, 2026 | MANCHESTER KEITH S Director | Sale | 325,000 | $34.07 | $11,072,750 | |
| Jun 26, 2026 | MANCHESTER KEITH S Director | Sale | 300,783 | $33.92 | $10,202,559 | |
| Jun 26, 2026 | Gold Daniel Allen Director | Sale | 325,000 | $34.07 | $11,072,750 | |
| Jun 26, 2026 | Gold Daniel Allen Director | Sale | 300,783 | $33.92 | $10,202,559 | |
| Jun 26, 2026 | QVT Financial LP Director by Deputization | Sale | 325,000 | $34.07 | $11,072,750 | |
| Jun 26, 2026 | QVT Financial LP Director by Deputization | Sale | 300,783 | $33.92 | $10,202,559 | |
| Jun 25, 2026 | Sukhatme Mayukh President & CIO | Sale | 500,000 | $34.13 | $17,065,000 | |
| Jun 24, 2026 | Venker Eric President & Immunovant CEO | Sale | 46,234 | $33.51 | $1,549,301 | |
| Jun 24, 2026 | Venker Eric President & Immunovant CEO | Sale | 153,766 | $33.05 | $5,081,966 | |
| May 22, 2026 | Venker Eric President & Immunovant CEO | Sale | 200,000 | $30.27 | $6,054,000 | |
| Apr 20, 2026 | Venker Eric President & Immunovant CEO | Sale | 200,000 | $29.59 | $5,918,000 | |
| Apr 16, 2026 | Gline Matthew CEO | Sale | 289,774 | $29.16 | $8,449,810 | |
| Apr 08, 2026 | Humes Jennifer Chief Accounting Officer | Sale | 13,538 | $28.37 | $384,073 | |
| Mar 26, 2026 | Fitzgerald Meghan Director | Sale | 70,000 | $27.45 | $1,921,500 | |
| Mar 17, 2026 | Venker Eric President & Immunovant CEO | Sale | 200,000 | $28.24 | $5,648,000 | |
| Mar 16, 2026 | Epperly Melissa B, Director | Sale | 41,861 | $28.68 | $1,200,573 | |
| Feb 23, 2026 | Torti Frank President and Vant Chair | Sale | 587,390 | $27.51 | $16,159,099 | |
| Feb 20, 2026 | Torti Frank President and Vant Chair | Sale | 1,012,610 | $27.15 | $27,492,362 | |
| Feb 19, 2026 | Torti Frank President and Vant Chair | Sale | 1,400,000 | $27.42 | $38,388,000 | |
| Feb 13, 2026 | Venker Eric President & Immunovant CEO | Sale | 200,000 | $26.49 | $5,298,000 | |
| Feb 13, 2026 | MANCHESTER KEITH S Director | Sale | 225,000 | $26.50 | $5,962,500 | |
| Feb 13, 2026 | MANCHESTER KEITH S Director | Sale | 150,784 | $26.49 | $3,994,268 | |
| Feb 13, 2026 | Gold Daniel Allen Director | Sale | 225,000 | $26.50 | $5,962,500 | |
| Feb 13, 2026 | Gold Daniel Allen Director | Sale | 150,784 | $26.49 | $3,994,268 | |
| Feb 13, 2026 | QVT Financial LP Director by Deputization | Sale | 225,000 | $26.50 | $5,962,500 | |
| Feb 13, 2026 | QVT Financial LP Director by Deputization | Sale | 150,784 | $26.49 | $3,994,268 | |
| Feb 12, 2026 | MANCHESTER KEITH S Director | Sale | 275,000 | $26.76 | $7,359,000 | |
| Feb 12, 2026 | MANCHESTER KEITH S Director | Sale | 150,000 | $26.72 | $4,008,000 | |
| Feb 12, 2026 | Gold Daniel Allen Director | Sale | 275,000 | $26.76 | $7,359,000 | |
| Feb 12, 2026 | Gold Daniel Allen Director | Sale | 150,000 | $26.72 | $4,008,000 | |
| Feb 12, 2026 | QVT Financial LP Director by Deputization | Sale | 275,000 | $26.76 | $7,359,000 | |
| Feb 12, 2026 | QVT Financial LP Director by Deputization | Sale | 150,000 | $26.72 | $4,008,000 | |
| Feb 11, 2026 | MANCHESTER KEITH S Director | Sale | 425,000 | $26.67 | $11,334,750 | |
| Feb 11, 2026 | Gold Daniel Allen Director | Sale | 425,000 | $26.67 | $11,334,750 | |
| Feb 11, 2026 | QVT Financial LP Director by Deputization | Sale | 425,000 | $26.67 | $11,334,750 | |
| Feb 09, 2026 | Sukhatme Mayukh President & CIO | Sale | 339,441 | $26.47 | $8,985,003 | |
| Jan 12, 2026 | Venker Eric President & Immunovant CEO | Sale | 200,000 | $21.92 | $4,384,000 | |
| Dec 31, 2025 | Sukhatme Mayukh President & CIO | Sale | 1,018,995 | $21.71 | $22,122,381 | |
| Dec 29, 2025 | Sukhatme Mayukh President & CIO | Sale | 311,873 | $21.74 | $6,780,119 | |
| Dec 23, 2025 | Pulik Richard CFO | Sale | 146,731 | $22.39 | $3,285,307 | |
| Dec 23, 2025 | Pulik Richard CFO | Sale | 260,000 | $22.45 | $5,837,000 | |
| Dec 17, 2025 | Gold Daniel Allen Director | Sale | 189,538 | $23.17 | $4,391,595 | |
| Dec 17, 2025 | Gold Daniel Allen Director | Sale | 155,076 | $23.02 | $3,569,850 | |
| Dec 17, 2025 | Gold Daniel Allen Director | Sale | 432,718 | $23.05 | $9,974,150 | |
| Dec 17, 2025 | MANCHESTER KEITH S Director | Sale | 189,538 | $23.17 | $4,391,595 | |
| Dec 17, 2025 | MANCHESTER KEITH S Director | Sale | 155,076 | $23.02 | $3,569,850 | |
| Dec 17, 2025 | MANCHESTER KEITH S Director | Sale | 432,718 | $23.05 | $9,974,150 | |
| Dec 17, 2025 | QVT Financial LP Director by Deputization | Sale | 189,538 | $23.17 | $4,391,595 | |
| Dec 17, 2025 | QVT Financial LP Director by Deputization | Sale | 155,076 | $23.02 | $3,569,850 | |
| Dec 17, 2025 | QVT Financial LP Director by Deputization | Sale | 432,718 | $23.05 | $9,974,150 | |
| Dec 17, 2025 | Sukhatme Mayukh President & CIO | Sale | 26,831 | $23.09 | $619,528 | |
| Dec 16, 2025 | Gold Daniel Allen Director | Sale | 642,282 | $23.08 | $14,823,869 | |
| Dec 16, 2025 | Gold Daniel Allen Director | Sale | 275,000 | $22.93 | $6,305,750 | |
| Dec 16, 2025 | MANCHESTER KEITH S Director | Sale | 642,282 | $23.08 | $14,823,869 | |
| Dec 16, 2025 | MANCHESTER KEITH S Director | Sale | 275,000 | $22.93 | $6,305,750 | |
| Dec 16, 2025 | QVT Financial LP Director by Deputization | Sale | 642,282 | $23.08 | $14,823,869 | |
| Dec 16, 2025 | QVT Financial LP Director by Deputization | Sale | 275,000 | $22.93 | $6,305,750 | |
| Dec 15, 2025 | Ramaswamy Vivek 10% owner | Sale | 353,745 | $22.05 | $7,800,077 | |
| Dec 15, 2025 | Gline Matthew CEO | Sale | 943,527 | $21.68 | $20,455,665 | |
| Dec 15, 2025 | Gline Matthew CEO | Sale | 566,116 | $21.68 | $12,273,395 | |
| Dec 15, 2025 | Gline Matthew CEO | Sale | 230,357 | $21.68 | $4,994,140 | |
| Dec 12, 2025 | Ramaswamy Vivek 10% owner | Sale | 1,975,858 | $21.96 | $43,389,842 | |
| Dec 11, 2025 | Ramaswamy Vivek 10% owner | Sale | 774,142 | $21.64 | $16,752,433 | |
| Dec 09, 2025 | Venker Eric President & Immunovant CEO | Sale | 200,000 | $20.85 | $4,170,000 | |
| Nov 19, 2025 | MANCHESTER KEITH S Director | Sale | 175,000 | $20.24 | $3,542,000 | |
| Nov 19, 2025 | MANCHESTER KEITH S Director | Sale | 125,000 | $20.16 | $2,520,000 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.